Literature DB >> 7474154

Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani.

R Bernier1, S J Turco, M Olivier, M Tremblay.   

Abstract

In this study, we demonstrated that the protozoan parasite Leishmania donovani and one of its major surface molecules, the lipophosphoglycan (LPG), can induce human immunodeficiency virus type 1 (HIV-1) expression in U1 and OM-10.1, two cell lines of monocytoid origin latently infected with HIV-1. Treatment of U1 cells with various concentrations of LPG (1, 5, and 10 microM) resulted in a dose-dependent secretion of tumor necrosis factor alpha (TNF-alpha). Suppression of LPG-induced HIV-1 expression by polyclonal anti-TNF-alpha antibodies further confirmed the involvement of this cytokine. Results from these studies indicate that the protozoan parasite L. donovani can induce the secretion of TNF-alpha that will function in an autocrine or paracrine manner to upregulate HIV-1 expression. Our data suggest for the first time that this protozoan parasite can be viewed as a potential cofactor in the pathogenesis of AIDS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474154      PMCID: PMC189654     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Leishmaniasis in France.

Authors:  D Jeannel; P Tuppin; G Brucker; M Danis; M Gentilini
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

Review 2.  The macrophage in the persistence and pathogenesis of HIV infection.

Authors:  H E Gendelman; J M Orenstein; L M Baca; B Weiser; H Burger; D C Kalter; M S Meltzer
Journal:  AIDS       Date:  1989-08       Impact factor: 4.177

3.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

Review 4.  Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection.

Authors:  M S Meltzer; D R Skillman; P J Gomatos; D C Kalter; H E Gendelman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Leishmaniasis and AIDS co-infection: the Spanish example.

Authors:  J Alvar
Journal:  Parasitol Today       Date:  1994-04

6.  Estimation of population at risk of infection and number of cases of Leishmaniasis.

Authors:  R W Ashford; P Desjeux; P Deraadt
Journal:  Parasitol Today       Date:  1992-03

7.  Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis.

Authors:  P Pisa; M Gennene; O Söder; T Ottenhoff; M Hansson; R Kiessling
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

8.  Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism.

Authors:  T Okamoto; H Ogiwara; T Hayashi; A Mitsui; T Kawabe; J Yodoi
Journal:  Int Immunol       Date:  1992-07       Impact factor: 4.823

Review 9.  The lipophosphoglycan of Leishmania parasites.

Authors:  S J Turco; A Descoteaux
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

10.  Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication.

Authors:  A Vyakarnam; J McKeating; A Meager; P C Beverley
Journal:  AIDS       Date:  1990-01       Impact factor: 4.177

View more
  19 in total

1.  Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.

Authors:  N Genois; B Barbeau; M Olivier; M J Tremblay
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain.

Authors:  J A Pineda; J Hernández-Quero; J A Gallardo; M A López-Ruz; M A Martínez-Pérez; J Macías; E Lissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

3.  Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines.

Authors:  Mona E E Elfaki; Eltahir A G Khalil; Anne S De Groot; Ahmed M Musa; Andres Gutierrez; Brima M Younis; Kawthar A M Salih; Ahmed M El-Hassan
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

Review 4.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  A study of haematological and bone marrow changes in symptomatic patients with human immune deficiency virus infection with special mention of functional iron deficiency, anaemia of critically ill and haemophagocytic lymphohistiocytosis.

Authors:  Jyoti Kotwal; Vikram Singh; Anupam Kotwal; Vibha Dutta; Velu Nair
Journal:  Med J Armed Forces India       Date:  2013-02-23

6.  Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication.

Authors:  D Wolday; H Akuffo; A Demissie; S Britton
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

8.  Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection.

Authors:  F J Medrano; C Rey; M Leal; C Cañavate; A Rubio; A Sánchez-Quijano; J Alvar; E Lissen
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 9.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 10.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.